Irisin Stimulates Browning of White Adipocytes Through Mitogen-Activated Protein Kinase p38 MAP Kinase and ERK MAP Kinase Signaling
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
The number and activity of brown adipocytes are linked to the ability of mammals to resist body fat accumulation. In some conditions, certain white adipose tissue (WAT) depots are readily convertible to a ‘‘brown-like’’ state, which is associated with weight loss. Irisin, a newly identified hormone, is secreted by skeletal muscles into circulation and promotes WAT “browning” with unknown mechanisms. In the current study, we demonstrated in mice that recombinant irisin decreased the body weight and improved glucose homeostasis. We further showed that irisin upregulated uncoupling protein-1 (UCP-1; a regulator of thermogenic capability of brown fat) expression. This effect was possibly mediated by irisin-induced phosphorylation of the p38 mitogen-activated protein kinase (p38 MAPK) and extracellular signal–related kinase (ERK) signaling pathways. Inhibition of the p38 MAPK by SB203580 and ERK by U0126 abolished the upregulatory effect of irisin on UCP-1. In addition, irisin also promoted the expression of betatrophin, another newly identified hormone that promotes pancreatic β-cell proliferation and improves glucose tolerance. In summary, our data suggest that irisin can potentially prevent obesity and associated type 2 diabetes by stimulating expression of WAT browning-specific genes via the p38 MAPK and ERK pathways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4 Irisin stimulates adipocyte browning via p38/ERK pathways. Primary rat adipocytes and 3T3-L1–derived adipocytes were treated with PBS (control [con]) or r-irisin (20 nmol/L) at indicated time points. Phosphorylated and total p38 and ERK1/2 in cell lysates were analyzed by Western blotting with anti–P-p38 or anti–P-ERK antibodies. Expression levels of P-p38 and total p38 protein in primary adipocytes (A) and 3T3-L1 adipocytes (B) were measured by corresponding densitometric quantification. Expression levels of P-ERK and total ERK in primary (C) and 3T3-L1–derived (D) adipocytes were measured with corresponding densitometric quantification. Densitometric analysis of the related bands was expressed as relative optical density of the bands, corrected using respective total protein as a loading control and normalized against the untreated control. Data were expressed as mean ± SE of three independent experiments. *P < 0.05; **P < 0.01 vs. control. E: 3T3-L1–derived adipocytes were pretreated for 30 min with p38 inhibitor SB023580 or ERK inhibitor U0126 at indicated concentrations followed by r-irisin treatment. Western blotting detected phosphorylated and total p38 and ERK proteins.](https://figures.cochat.ai/paper-figures/7a3abc917f3847829d9e87bf6af4124b/irisin-stimulates-browning-of-white-adipocytes-through-mitogen-activated-protein-figure-4.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Irisin is a PPARγ-coactivator-1α (PGCα)-dependent myokine that stimulates browning in subcutaneous adipose tissues and induces increased energy expenditure, which improves obesity and IR through the MAPK and ERK pathways [92,93].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [93]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Multiple molecular mechanisms lead to this WAT transformation, including the activation of PGC-1α within adipocytes, the stimulation of AMPK, the upregulation of SIRT1 expression and activity, and the engagement of the p38 mitogen-activated protein kinase (p38 MAPK) and extracellular signal-regulated kinase (ERK) signaling pathways.”
From Exercise-Induced Muscle–Fat Crosstalk: Molecular Mediators and Their Pharmacological Modulation for the Maintenance of Metabolic Flexibility in Aging (2025) · cites this paper as [56]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These cascades collectively promote the transcription of thermogenic and mitochondrial genes such as UCP1, PR domain-containing 16 (PRDM16), transmembrane protein 26 (TMEM26), and CD137 or tumor necrosis factor receptor superfamily member 9 (TNFRSF9), as seen in Figure 2 [56,57].”
From Exercise-Induced Muscle–Fat Crosstalk: Molecular Mediators and Their Pharmacological Modulation for the Maintenance of Metabolic Flexibility in Aging (2025) · cites this paper as [56]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“An in vitro experiment conducted on adipocyte cultures derived from male Sprague–Dawley rats demonstrated that irisin activates UCP1 expression through the phosphorylation of p38 MAPK and ERK, signaling pathways known to mediate cellular thermogenic responses [56].”
From Exercise-Induced Muscle–Fat Crosstalk: Molecular Mediators and Their Pharmacological Modulation for the Maintenance of Metabolic Flexibility in Aging (2025) · cites this paper as [56]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Zhang, Y et al. (2014), stimulated RAW 264.7 macrophages with lipopolysaccharide (LPS), and showed that irisin (0–100 nM) significantly reduced the activation of the Toll-like receptor 4 (TLR4) MyD88, concomitantly reducing the phosphorylation of nuclear factor-κB (NF-κB).”
From Exercise-Induced Muscle–Fat Crosstalk: Molecular Mediators and Their Pharmacological Modulation for the Maintenance of Metabolic Flexibility in Aging (2025) · cites this paper as [56]
Experimental — accuracy not yet measured
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Betatrophin: A Hormone that Controls Pancreatic β Cell Proliferation
Yi, P., Park, J.-S., & Melton, D. A. (2013) · Cell · doi:10.1016/j.cell.2013.04.008 · Cited by 449
RetractedBrown Adipose Tissue: Function and Physiological Significance
CANNON, B., & NEDERGAARD, J. (2004) · Physiological Reviews · doi:10.1152/physrev.00015.2003 · Cited by 6,433 · cited 1×
“, triglycerides), whereas brown adipocytes consume energy (5,6).”
A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis
Boström, P., Wu, J., Jedrychowski, M. P., Korde, A., Ye, L., Lo, J. C., Rasbach, K. A., Boström, E. A., Choi, J. H., Long, J. Z., et al. (2012) · Nature · doi:10.1038/nature10777 · Cited by 4,810 · cited 1×
“Boström et al. (12) identified PPARa as a potential factor for the expression of UCP-1, but other pathways may also be involved.”
BackgroundBeige Adipocytes Are a Distinct Type of Thermogenic Fat Cell in Mouse and Human
Wu, J., Boström, P., Sparks, L. M., Ye, L., Choi, J. H., Giang, A.-H., Khandekar, M., Virtanen, K. A., Nuutila, P., Schaart, G., et al. (2012) · Cell · doi:10.1016/j.cell.2012.05.016 · Cited by 3,319 · cited 5×
“The increased expression of beige cell marker TMEM26 (24) and brown cell markers such as Cidea and Cox7a indicated that the r-irisin may exert effects on converting white adipose cells into beige-like adipocytes and brown adipose cells.”
BackgroundInfluentialPRDM16 controls a brown fat/skeletal muscle switch
Seale, P., Bjork, B., Yang, W., Kajimura, S., Chin, S., Kuang, S., Scimè, A., Devarakonda, S., Conroe, H. M., Erdjument-Bromage, H., et al. (2008) · Nature · doi:10.1038/nature07182 · Cited by 2,347 · cited 1×
“One is the classical brown fat that arises from a myf5, muscle-like cell lineage (29,30).”
BackgroundDevelopmental Origin of Fat: Tracking Obesity to Its Source
Gesta, S., Tseng, Y.-H., & Kahn, C. R. (2007) · Cell · doi:10.1016/j.cell.2007.10.004 · Cited by 1,508 · cited 2×
“Obesity develops when energy intake exceeds energy expenditure (1) and is principally characterized by excess adipose tissue (2,3).”
BackgroundFeldmann, H. M., Golozoubova, V., Cannon, B., & Nedergaard, J. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2008.12.014 · Cited by 1,318 · cited 1×
“in BAT activity can profoundly affect adaptive thermogenesis and glucose homeostasis (7,8).”
BackgroundPetrovic, N., Walden, T. B., Shabalina, I. G., Timmons, J. A., Cannon, B., & Nedergaard, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.053942 · Cited by 1,263 · cited 1×
“These brown fat cells, UCP-1 positive, are designated as beige or brown-in-white (brite) cells (11,34).”
BackgroundPrdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice
Seale, P., Conroe, H. M., Estall, J., Kajimura, S., Frontini, A., Ishibashi, J., Cohen, P., Cinti, S., & Spiegelman, B. M. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44271 · Cited by 1,252 · cited 2×
“In several rodent models, browning of WAT depots appears to be protective against diet-induced metabolic disorders, including obesity and diabetes (10,11).”
BackgroundRegulation of pgc-1α, a nodal regulator of mitochondrial biogenesis
Fernandez-Marcos, P. J., & Auwerx, J. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.001917 · Cited by 1,237 · cited 1×
“PGC-1a, a master regulator of mitochondrial biogenesis and function, acts as a cold-inducible protein that controls adaptive thermogenesis in BAT, and its expression is regulated by the activation of cAMP/PKA/p38 MAPK signaling pathways (35,36).”
Background
Cited by
Items 101–200 of 728
Wu, F., Song, H., Zhang, Y., Zhang, Y., Mu, Q., Jiang, M., Wang, F., Zhang, W., Li, L., Li, H., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0134662 · Cited by 93
Self-citationImpact of Conventional and Atypical MAPKs on the Development of Metabolic Diseases
Kassouf, T., & Sumara, G. (2020) · Biomolecules · doi:10.3390/biom10091256 · Cited by 101
Abu‐Farha, M., Ghosh, A., Al‐Khairi, I., Madiraju, S. R. M., Abubaker, J. A., & Prentki, M. (2020) · Progress in Lipid Research · doi:10.1016/j.plipres.2020.101067 · Cited by 97
The p38–PGC-1α–irisin–betatrophin axis: Exploring new pathways in insulin resistance
Sanchis-Gomar, F., & Perez-Quilis, C. (2014) · Adipocyte · doi:10.4161/adip.27370 · Cited by 92
“More importantly, irisin also promotes the expression of betatrophin.(8) Therefore, PGC1-α expression in muscle stimulates an increase in the expression of FNDC5 and secreted irisin and the latter acts on white adipose cells to stimulate UCP1expression, mediated via activation of p38 MAPK, and promotes the expression…”
BackgroundInfluentialIs irisin the new player in exercise-induced adaptations or not? A 2017 update
Fatouros, I. G. (2017) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2017-0674 · Cited by 101
“Irisin itself has consistently induced browning in brite adipocytes but not in brown adipocytes [7, 106, 107].”
BackgroundIrisin promotes proliferation but inhibits differentiation in osteoclast precursor cells
Ma, Y., Qiao, X., Zeng, R., Cheng, R., Zhang, J., Luo, Y., Nie, Y., Hu, Y., Yang, Z., Zhang, J., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201700983rr · Cited by 90
The Role of Irisin in Alzheimer’s Disease
Kim, O. Y., & Song, J. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7110407 · Cited by 89
“Recent studies have reported that many metabolic disorders such as obesity, type 2 diabetes (T2DM), atherosclerosis, and cardiovascular disease, have been observed in patients with AD [5,6].”
BackgroundInfluentialDecreased irisin secretion contributes to muscle insulin resistance in high-fat diet mice.
Yang, Z., Xu, C., Chen, Y., & Zhao, Q. (2015) · Europe PMC (PubMed Central) · Cited by 105
Harnessing Muscle–Liver Crosstalk to Treat Nonalcoholic Steatohepatitis
Chakravarthy, M. V., Siddiqui, M. S., Forsgren, M. F., & Sanyal, A. J. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.592373 · Cited by 88
The Role of Exercise, Diet, and Cytokines in Preventing Obesity and Improving Adipose Tissue
Atakan, M. M., Koşar, Ş. N., Güzel, Y., Tin, H. T., & Yan, X. (2021) · Nutrients · doi:10.3390/nu13051459 · Cited by 87
“They also showed that irisin stimulated UCP-1 expression and the expression of betatrophin, which is a hormone that promotes pancreatic β-cell proliferation and improves glucose tolerance [320].”
BackgroundIrisin Is Regulated by CAR in Liver and Is a Mediator of Hepatic Glucose and Lipid Metabolism
Mo, L., Shen, J., Liu, Q., Zhang, Y., Kuang, J., Pu, S., Cheng, S., Zou, M., Jiang, W., Jiang, C., et al. (2016) · Molecular Endocrinology · doi:10.1210/me.2015-1292 · Cited by 88
Self-citationIrisin, an exercise-induced bioactive peptide beneficial for health promotion during aging process
Zhang, H., Wu, X., Liang, J., Kirberger, M., & Chen, N. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101680 · Cited by 88
Shi, G., Tang, N., Qiu, J., Zhang, D., Huang, F., Cheng, Y., Ding, K., Li, W., Zhang, P., & Tan, X. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.08.148 · Cited by 88
Zhou, W., Shi, Y., Wang, H., Chen, L., Yu, C., Zhang, X., Yang, L., Zhang, X., & Wu, A. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00811-2 · Cited by 91
Self-citationImplication of Circulating Irisin Levels with Brown Adipose Tissue and Sarcopenia in Humans
Choi, H. Y., Kim, S., Park, J. W., Lee, N. S., Hwang, S. Y., Huh, J. Y., Hong, H. C., Yoo, H. J., Baik, S. H., Youn, B.-S., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1195 · Cited by 84
A Strategy for Discovery of Endocrine Interactions with Application to Whole-Body Metabolism
Seldin, M. M., Koplev, S., Rajbhandari, P., Vergnes, L., Rosenberg, G. M., Meng, Y., Pan, C., Phuong, T. M. N., Gharakhanian, R., Che, N., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.03.015 · Cited by 84
“…test the hypothesis, we treated 3T3L1 adipocytes for the first 3 days of brown differentiation with vehicle or 200 ng/mL NOTUM, a protocol that has been previously used to test whether various pharmacologic agents could promote beiging of 3T3L1 adipocytes (Asano et al., 2014; Zhang et al., 2014).”
MethodSelf-citationLu, L., Ma, J., Tang, J., Yang, L., Zheng, Q., Chen, S., Gao, E., Ren, J. T., Yang, L., & Yang, J. Z. (2020) · Clinical and Translational Medicine · doi:10.1002/ctm2.166 · Cited by 88
Self-citationSarcopenic obesity: Myokines as potential diagnostic biomarkers and therapeutic targets?
Guo, A., Li, K., & Xiao, Q. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.111022 · Cited by 83
So, W. Y., & Leung, P. S. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.07.022 · Cited by 83
AlKhairi, I., Cherian, P., Abu-Farha, M., Madhoun, A. A., Nizam, R., Melhem, M., Jamal, M., Al-Sabah, S., Ali, H., Tuomilehto, J., et al. (2019) · Cells · doi:10.3390/cells8101283 · Cited by 82
Kuchay, M. S., Martínez‐Montoro, J. I., Kaur, P., Fernández‐García, J. C., & Ramos‐Molina, B. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101696 · Cited by 93
Frühbeck, G., Fernández-Quintana, B., Paniagua, M., Hernández‐Pardos, A. W., Valentí, V., Moncada, R., Catalán, V., Becerril, S., Gómez‐Ambrosi, J., Portincasa, P., et al. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154261 · Cited by 84
Park, E. J., Myint, P. K., Ito, A., Appiah, M. G., Darkwah, S. O., Kawamoto, E., & Shimaoka, M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.588066 · Cited by 96
“, 2015), preadipocytes (Zhang et al., 2014), gastrointestinal cancers (Aydin et al.”
BackgroundInfluentialBrown adipose tissue: a potential target in the fight against obesity and the metabolic syndrome
Poekes, L., Lanthier, N., & Leclercq, I. A. (2015) · Clinical Science · doi:10.1042/cs20150339 · Cited by 80
Irisin, a unique non-inflammatory myokine in stimulating skeletal muscle metabolism
Vaughan, R. A., Gannon, N. P., Mermier, C. M., & Conn, C. A. (2015) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-015-0433-9 · Cited by 82
Crosstalk Between Muscle and Bone Via the Muscle-Myokine Irisin
Colaianni, G., Mongelli, T., Colucci, S. C., Cinti, S., & Grano, M. (2016) · Current Osteoporosis Reports · doi:10.1007/s11914-016-0313-4 · Cited by 81
Irisin in humans: recent advances and questions for future research
Boström, P., Fernández‐Real, J. M., & Mantzoros, C. S. (2013) · Metabolism · doi:10.1016/j.metabol.2013.11.009 · Cited by 87
Irisin Inhibits Atherosclerosis by Promoting Endothelial Proliferation Through microRNA126‐5p
Zhang, Y., Song, H., Zhang, Y., Wu, F., Mu, Q., Jiang, M., Wang, F., Zhang, W., Li, L., Shao, L., et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.004031 · Cited by 77
“Irisin activates profound changes in the subcutaneous adipose tissue, stimulating browning and uncoupling protein 1 expression.(8,9) The presence of human irisin in blood was demonstrated by a recent study using quantitative mass spectrometry.”
BackgroundMethodSelf-citationThe serum level of irisin, but not asprosin, is abnormal in polycystic ovary syndrome patients
Chang, C. L., Huang, S. Y., Hsu, Y. C., Chin, T. H., & Soong, Y. K. (2019) · Scientific Reports · doi:10.1038/s41598-019-42061-9 · Cited by 91
The “irisin system”: From biological roles to pharmacological and nutraceutical perspectives
Flori, L., Testai, L., & Calderone, V. (2021) · Life Sciences · doi:10.1016/j.lfs.2020.118954 · Cited by 76
Plasma irisin levels predict telomere length in healthy adults
Rana, K. S., Arif, M., Hill, E. J., Aldred, S., Nagel, D. A., Nevill, A., Randeva, H. S., Bailey, C. J., Bellary, S., & Brown, J. E. (2014) · AGE · doi:10.1007/s11357-014-9620-9 · Cited by 76
“The possibility exists that irisin has direct effects upon PBMCs. Previously published data has shown that irisin activates signalling pathways associated with the regulation of cellular proliferation including p38 MAPK (Zhang et al. 2013) which has previously been shown to regulate expression of human telomerase reve…”
BackgroundMa, C., Ding, H., Deng, Y., Liu, H., Xiong, X., & Yang, Y. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.620608 · Cited by 109
Heart Failure With Preserved Ejection Fraction Induces Beiging in Adipose Tissue
Valero-Muñoz, M., Li, S., Wilson, R. M., Hulsmans, M., Aprahamian, T., Fuster, J. J., Nahrendorf, M., Scherer, P. E., & Sam, F. (2016) · Circulation: Heart Failure · doi:10.1161/circheartfailure.115.002724 · Cited by 75
“that phosphorylation of p38 MAPK can induce UCP-1 protein expression.(23,29) In eWAT, p38 MAPK phosphorylation was increased by 137±27% in HFpEF when compared with sham mice (P<0.”
ResultSelf-citationLi, Y., & Teng, C. (2014) · Journal of drug targeting · doi:10.3109/1061186x.2014.928715 · Cited by 83
“#: down-regulated This table was created in part according to summaries in references [70].”
BackgroundAngptl8 mediates food-driven resetting of hepatic circadian clock in mice
Chen, S., Feng, M., Zhang, S., Dong, Z., Wang, Y., Zhang, W., & Liu, C. (2019) · Nature Communications · doi:10.1038/s41467-019-11513-1 · Cited by 79
The role of sex, adiposity, and gonadectomy in the regulation of irisin secretion
Zügel, M., Qiu, S., Laszlo, R., Bosnyák, E., Weigt, C., Müller, D., Diel, P., Steinacker, J. M., & Schumann, U. (2016) · Endocrine · doi:10.1007/s12020-016-0913-x · Cited by 74
“Irrespective of the controversy regarding a point mutation within the start codon of FNDC5 and its consequences for the secretion of irisin in humans [9], irisin has the potential to be developed as a pharmacological agent, since injections of recombinant irisin in obese, diabetic mice led to significant reductions in…”
BackgroundWu, T., Liu, Q., Li, Y., Li, H., Chen, L., Yang, X., Tang, Q., Pu, S., Kuang, J., Li, R., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20201203 · Cited by 74
Self-citationMitostasis, Calcium and Free Radicals in Health, Aging and Neurodegeneration
Godoy, J. A., Ríos, J. A., Picón-Pagès, P., Herrera-Fernández, V., Swaby, B., Crepin, G., Vicente, R., Fernández‐Fernández, J. M., & Muñoz, F. J. (2021) · Biomolecules · doi:10.3390/biom11071012 · Cited by 76
“IP3R and VDAC channels found in MAMs can also transport”
BackgroundThe Emerging Role of Irisin in Cardiovascular Diseases
Fu, J., Li, F., Tang, Y., Cai, L., Zeng, C., Yang, Y., & Yang, J. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.022453 · Cited by 90
Regulation of brown adipocyte metabolism by myostatin/follistatin signaling
Singh, R., Braga, M., & Pervin, S. (2014) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2014.00060 · Cited by 70
“Most recently, irisin, a PGC-1α and exercise inducible myokine has been reported to stimulate browning of WAT through p38 MAP Kinase and ERK signaling (Zhang et al., 2014).”
BackgroundANGPTL8 (betatrophin) role in diabetes and metabolic diseases
Abu‐Farha, M., Abubaker, J. A., & Tuomilehto, J. O. (2017) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2919 · Cited by 72
“ANGPTL8 expression in brown adipose tissues has been recently linked to the action of another browning‐related myokine called irisin.(64) In cell models, irisin has been found to increase the expression of ANGPTL8 during adipocyte differentiation.”
BackgroundLiu, X., Mujahid, H., Rong, B., Lu, Q., Zhang, W., Li, P., Li, N., Liang, E., Wang, Q., Tang, D., et al. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13360 · Cited by 70
Self-citationNie, T., Zhao, S., Mao, L., Yang, Y., Sun, W., Lin, X., Liu, S., Li, K., Sun, Y., Li, P., et al. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14139 · Cited by 73
“…demonstrated to treat obesity by increasing adipocyte thermogenesis, but a critical problem is that few people like to regard obesity as an illness and treat it medicinally (Buemann et al., 2000; Fisher et al., 2012; Bi et al., 2014; Zhang et al., 2014; Wang et al., 2015; Baskaran et al., 2016).”
BackgroundAmanat, S., Sinaei, E., Panji, M., MohammadporHodki, R., Bagheri-Hosseinabadi, Z., Asadimehr, H., Fararouei, M., & Dianatinasab, A. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.562895 · Cited by 70
“This hypothesis was supported by the results of an animal study, in which irisin-1 improved hyperinsulinemia and glucose tolerance in mice with a high-fat diet (Zhang et al., 2014).”
ResultThe role of the ERK signaling pathway in promoting angiogenesis for treating ischemic diseases
Song, Y., Liang, D., Liu, D.-K., Lin, L., Zhang, L., & Yang, W. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1164166 · Cited by 71
Ebert, T., Kralisch, S., Wurst, U., Lössner, U., Kratzsch, J., Blüher, M., Stümvoll, M., Tönjes, A., & Faßhauer, M. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-0815 · Cited by 69
Winn, N. C., Grunewald, Z. I., Liu, Y., Heden, T. D., Nyhoff, L. M., & Kanaley, J. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170690 · Cited by 72
Zheng, S., Chen, N., Kang, X.-J., Hu, Y., & Shi, S. (2021) · Endocrine · doi:10.1007/s12020-021-02875-y · Cited by 80
Emerging Regulation and Function of Betatrophin
Tseng, Y., Yeh, Y., Chen, W.-J., & Lin, K. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151223640 · Cited by 71
“[21], reported that irisin, a newly defined peptide encoded by the fibronectin type III domain-containing 5 (FNDC5) gene, induces betatrophin expression.”
BackgroundMKK6 controls T3-mediated browning of white adipose tissue
Matesanz, N., Bernardo, E., Acín‐Pérez, R., Manieri, E., Perez‐Sieira, S., Hernández‐Cosido, L., Montalvo-Romeral, V., Mora, A., Rodríguez, E., Leiva‐Vega, L., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00948-z · Cited by 70
A Review on the Role of Irisin in Insulin Resistance and Type 2 Diabetes Mellitus.
Gizaw, M., Anandakumar, P., & Tolessa, D. (2017) · PubMed · doi:10.3831/kpi.2017.20.029 · Cited by 68
RetractedTaming the Flames: Targeting White Adipose Tissue Browning in Hypermetabolic Conditions
Abdullahi, A., & Jeschke, M. G. (2017) · Endocrine Reviews · doi:10.1210/er.2017-00163 · Cited by 75
Increased levels of irisin in people with long‐standing Type 1 diabetes
Espes, D., Lau, J., & Carlsson, P. (2015) · Diabetic Medicine · doi:10.1111/dme.12731 · Cited by 67
Chang, C. L., Huang, S. Y., Soong, Y. K., Cheng, P. J., Wang, C.-J., & Liang, I. T. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1180 · Cited by 65
Chen, Z., Zhang, Y., Zhao, F., Yin, C., Yang, C., Wang, X., Wu, Z., Liang, S., Li, D., Lin, X., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041259 · Cited by 75
“Abbreviations AKT v-akt murine thymoma viral oncogene homolog 1 ALP/Alp alkaline phosphatase ARS Alizarin red staining BMSCs bone marrow stromal cells BMD bone mineral density BMP bone morphogenetic protein BV/TV bone volume to tissue volume (bone volume fraction) CCK-8 Cell Counting Kit-8 CDK2 cyclin-dependent kinase…”
BackgroundSelf-citationSerum irisin concentration in women with gestational diabetes
Kuźmicki, M., Telejko, B., Lipińska, D., Pliszka, J., Szamatowicz, M., Wilk, J., Zbucka-Krętowska, M., Laudański, P., Kretowski, A. J., Górska, M., et al. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2014.920006 · Cited by 66
“Studies in mice have shown that FNDC5/irisin overexpression induces browning of white adipose tissue, thereby increasing total body energy expenditure and protecting from diet induced obesity and diabetes [1,5].”
BackgroundAdipose–Muscle Crosstalk in Age-Related Metabolic Disorders: The Emerging Roles of Adipo-Myokines
Fang, P., She, Y., Yu, M., Min, W., Shang, W., & Zhang, Z. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101829 · Cited by 62
Scheel, A. K., Espelage, L., & Chadt, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094759 · Cited by 71
“These findings were supported by other studies, which presented that attenuating exerciseinduced secretion of irisin by either an anti-FNDC5 antibody or loss-of-function Fndc5mutation leads to impaired WAT browning [117] and impaired exercise-induced metabolic improvements [119].”
BackgroundResultIrisin: A true, circulating hormone
Pοlyzos, S. A., Mathew, H., & Mantzoros, C. S. (2015) · Metabolism · doi:10.1016/j.metabol.2015.09.001 · Cited by 62
Anti-diabetic activity of recombinant irisin in STZ-induced insulin-deficient diabetic mice
Duan, H., Ma, B., Ma, X., Wang, H., Ni, Z., Wang, B., Li, X., Jiang, P., Umar, M., & Li, M. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.12.049 · Cited by 71
Association of Serum Irisin Concentrations with Presence and Severity of Coronary Artery Disease
Deng, W. (2016) · Medical Science Monitor · doi:10.12659/msm.897376 · Cited by 62
“Irisin stimulates browning of white adipocytes through mitogen-activated protein kinase p38 MAP kinase and ERK MAP kinase signaling [16].”
BackgroundFndc5 loss‐of‐function attenuates exercise‐induced browning of white adipose tissue in mice
Xiong, Y., Wu, Z., Zhang, B., Wang, C., Mao, F., Liu, X., Hu, K., Sun, X., Jin, W., & Kuang, S. (2019) · The FASEB Journal · doi:10.1096/fj.201801754rr · Cited by 61
Exercise–Linked Irisin: Consequences on Mental and Cardiovascular Health in Type 2 Diabetes
Sousa, R. A. L. D., Caria, A. C. I., & Souza, B. S. D. F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042199 · Cited by 73
“, showed that exercise induces positive changes in T2DM, including increased irisin levels [50].”
BackgroundZheng, Z., Xu, Y.-Y., Liu, W., Zhang, Y., Zhang, C., Liu, H.-L., Zhang, X., Liu, R., Zhang, Y., Shi, M.-Y., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.11.012 · Cited by 70
Self-citationGao, S., Li, F., Li, H., Huang, Y., Liu, Y., & Chen, Y. (2016) · PLOS ONE · doi:10.1371/journal.pone.0147480 · Cited by 61
Irisin Recovers Osteoarthritic Chondrocytes In Vitro
Vadalà, G., Giacomo, G. D., Ambrosio, L., Cannata, F., Cicione, C., Papalia, R., & Denaro, V. (2020) · Cells · doi:10.3390/cells9061478 · Cited by 70
“In osteoarthritic cartilage, excessive amounts of basic fibroblast growth factor are released upon mechanical loading and activate several transduction pathways involving different MAPK, including ERK and p38.”
BackgroundInfluentialRole of Irisin on the bone–muscle functional unit
Colaianni, G., & Grano, M. (2015) · BoneKEy Reports · doi:10.1038/bonekey.2015.134 · Cited by 60
“The firstly described role for Irisin was its ability to induce the so-called ‘browning response’ in white fat adipose tissue.10 During the same time, it has been reported that this inducible form of brown adipose (iBAT) is anabolic for the skeleton.37 Studies on transgenic mice overexpressing FoxC2 in the adipose tis…”
BackgroundParkin‐mediated mitophagy is downregulated in browning of white adipose tissue
Taylor, D., & Gottlieb, R. A. (2017) · Obesity · doi:10.1002/oby.21786 · Cited by 60
“stimuli and upon induction can exhibit characteristics of multiple adipocyte lineages (18,19).”
Bonfante, I. L. P., Chacon‐Mikahil, M. P. T., Brunelli, D. T., Gáspari, A. F., Duft, R. G., Lopes, W. A., Bonganha, V., Libardi, C. A., & Cavaglieri, C. R. (2017) · European Journal of Sport Science · doi:10.1080/17461391.2017.1296025 · Cited by 60
Lu, H., Tang, S., Xue, C., Liu, Y., Wang, J., Zhang, W., Luo, W., & Chen, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102456 · Cited by 59
“Furthermore, our data showed that MOTS-c stimulated thermogenic gene expression via activation of the ERK pathway [30].”
BackgroundCombating Obesity With Thermogenic Fat: Current Challenges and Advancements
Pan, R., Zhu, X., Maretich, P., & Chen, Y. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00185 · Cited by 68
Xin, C., Zhang, Z., Gao, G., Ding, L., Yang, C., Wang, C., Liu, Y., Guo, Y., Yang, X., Zhang, L., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.565160 · Cited by 64
“…mice were administered with vehicle (PBS) or irisin (0.5 mg/g, irisin/body weight, Abnova, Taiwan, China)(a dose determined from previous report (Zhang et al., 2014) before receiving sham-operation or myocardial I/R. Thirty minutes after injection, mice were subjected to 30 min of myocardial…”
MethodInfluentialYan, C., Zeng, T., Lee, K., Nobis, M., Loh, K., Gou, L., Xia, Z., Gao, Z., Bensellam, M., Hughes, W. E., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22925-3 · Cited by 66
The Effect of Irisin as a Metabolic Regulator and Its Therapeutic Potential for Obesity
Li, H., Wang, F., Yang, M., Sun, J., Zhao, Y., & Tang, D. (2021) · International Journal of Endocrinology · doi:10.1155/2021/6572342 · Cited by 58
“Although it has been demonstrated that irisin plays a pivotal role in inducing fat browning and regulation of energy expenditure in animal studies [8, 79, 82], the function of irisin in humans remains to be elucidated.”
BackgroundSelf-citationMyokines: Metabolic regulation in obesity and type 2 diabetes
Chen, Z.-T., Weng, Z.-X., Lin, J. D., & Meng, Z.-X. (2024) · Life Metabolism · doi:10.1093/lifemeta/loae006 · Cited by 58
“Upregulated UCP1, a thermogenic regulator in brown adipose tissue (BAT), contributes to the induction of white-to-brown shift [64, 87].”
Uncovering the Role of p38 Family Members in Adipose Tissue Physiology
Leiva, M., Matesanz, N., Pulgarín-Alfaro, M., Nikolić, I., & Sabio, G. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.572089 · Cited by 67
FNDC5/irisin, a molecular target for boosting reward-related learning and motivation
Zsuga, J., Tajti, G., Papp, C., Juhász, B., & Gesztelyi, R. (2016) · Medical Hypotheses · doi:10.1016/j.mehy.2016.02.020 · Cited by 64
“A recent report showed the beneficial effect of recombinant irisin in mice by decreasing body weight and improving glucose homeostasis parallel to upregulating the expression of thermogenic genes such as UCP-1 and PGC1a, possibly via p38 mitogen-activated protein kinase (p38 MAPK) and extracellular signal-related kina…”
BackgroundSharma, A. K., Singh, V., Gera, R., Purohit, M. P., & Ghosh, D. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0133-7 · Cited by 60
Yano, N., Zhang, L., Wei, D., Dubielecka, P. M., Wei, L., Zhuang, S., Zhu, P., Qin, G., Liu, P. Y., Chin, Y. E., et al. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00219.2019 · Cited by 58
Hu, W., Li, M., Sun, W., Li, Q., Xi, H., Qiu, Y., Wang, R., Ding, Q., Wang, Z., Yu, Y., et al. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105917 · Cited by 64
Vieira-Potter, V. J., Padilla, J., Park, Y.-M., Welly, R. J., Scroggins, R. J., Britton, S. L., Koch, L. G., Jenkins, N. T., Crissey, J. M., Zidon, T., et al. (2015) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00401.2014 · Cited by 56
“Insulin resistance develops after OVX in rodents (48, 54) and menopause or hysterectomy in humans (12, 36) via mechanisms that are incompletely understood but that likely involve increased accretion of WAT.”
Pérez-Sotelo, D., Roca-Rivada, A., de la Torre, I. B., Baltar, J., Castro, A. I., Domínguez, E., Collado, M., Casanueva, F. F., & Pardo, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-16602-z · Cited by 60
Zhao, Y. T., Wang, J., Yano, N., Zhang, L. X., Wang, H., Zhang, S., Qin, G., Dubielecka, P. M., Zhuang, S., Liu, P. Y., et al. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27037 · Cited by 56
Self-citationMarrano, N., Biondi, G., Borrelli, A., Cignarelli, A., Perrini, S., Laviola, L., Giorgino, F., & Natalicchio, A. (2021) · Biomolecules · doi:10.3390/biom11020286 · Cited by 56
An update on the validity of irisin assays and the link between irisin and hepatic metabolism
Pοlyzos, S. A., & Mantzoros, C. S. (2015) · Metabolism · doi:10.1016/j.metabol.2015.06.005 · Cited by 58
Amengual, J., García‐Carrizo, F., Arreguín, A., Mušinović, H., Granados, N., Palou, A., Bonet, M. L., & Ribot, J. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000488422 · Cited by 66
Dianatinasab, A., Koroni, R., Bahramian, M., Bagheri-Hosseinabadi, Z., Vaismoradi, M., Fararouei, M., & Amanat, S. (2020) · Journal of Exercise Science & Fitness · doi:10.1016/j.jesf.2020.06.004 · Cited by 56
“38 In the second hypothesis, an increase in serum irisin in adiposity suggests potential irisin resistance.”
BackgroundAzevedo, V. Z., Silaghi, C. A., Maurel, T., Silaghi, H., Ratziu, V., & Pais, R. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2021.774030 · Cited by 67
“Irisin improves glucose metabolism, increases adipocyte energy expenditure, modulates the expression of enzymes that inhibit lipid accumulation and reduces weight and has a positive effect on hepatic steatosis (24, 119, 120).”
BackgroundIrisin: An anti-inflammatory exerkine in aging and redox-mediated comorbidities
Trettel, C. D. S., Pelozin, B. R. D. A., Barros, M. P., Bachi, A. L. L., Braga, P. G. S., Momesso, C. M., Furtado, G. E., Valente, P. A., de Oliveira, E. M., Hogervorst, E., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1106529 · Cited by 65
“(2014) showed that chemical inhibition of the p38 or ERK pathways causes a significant reduction in the action of irisin on the adipocyte UCP-1 protein (61).”
BackgroundHsieh, C., Ho, M.-Y., Wen, M., Chen, C., Hsieh, M., Lin, C., Yeh, J., Tsai, M., Yang, C., Wu, V. C., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.11.072 · Cited by 59
Singh, R., Braga, M., Reddy, S. T., Lee, S.-J., Parveen, M., Grijalva, V., Vergnes, L., & Pervin, S. (2017) · Endocrinology · doi:10.1210/en.2016-1607 · Cited by 54
Imran, K. M., Rahman, N., Yoon, D., Jeon, M., Lee, B., & Kim, Y. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.08.001 · Cited by 69
“Irisin induces browning of white adipocytes via p38-MAPK and ERK MAP kinase signaling [49].”
BackgroundBiondi, G., Marrano, N., Borrelli, A., Rella, M., Palma, G., CALDERONI, I., Siciliano, E., Lops, P., Giorgino, F., & Natalicchio, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105522 · Cited by 69
“All these data support the hypothesis that irisin may be a compensatory mechanism to offset HFD/obesity-induced insulin resistance by increasing energy expenditure [234,235] and insulin secretion to prevent diabetes.”
Backgroundde Oliveira, M., Síbio, M. T. D., Mathias, L. S., Rodrigues, B. M., Sakalem, M. E., & Nogueira, C. R. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.110917 · Cited by 61
Obesity and male fertility disorders
Cannarella, R., Crafa, A., Curto, R., Condorelli, R. A., Vignera, S. L., & Calogero, A. E. (2024) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2024.101273 · Cited by 74
Merlin, J., Evans, B. A., Dehvari, N., Sato, M., Bengtsson, T., & Hutchinson, D. S. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500251 · Cited by 62
“Irisin acts synergistically with fibroblast growth factor 21 (FGF21) to increase oxygen consumption in human adipocytes [133], although [134] did not observe any effects of irisin on UCP1, Zic1, or PPAR- mRNA levels in human adipocytes.”
BackgroundInfluentialMagnolol promotes thermogenesis and attenuates oxidative stress in 3T3-L1 adipocytes
Parray, H. A., Lone, J. B., Park, J. P., Choi, J. W., & Yun, J. W. (2018) · Nutrition · doi:10.1016/j.nut.2018.01.017 · Cited by 54
Qiu, Y., Sun, Y., Xu, D., Yang, Y., Liu, X., Wei, Y., Chen, Y., Feng, Z., Li, S., Reyad‐ul‐Ferdous, M., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.10.019 · Cited by 56
Self-citationLv, Y., Zhang, S.-Y., Liang, X., Zhang, H., Xu, Z., Liu, B., Xu, M.-J., Jiang, C., Shang, J., & Wang, X. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.735563 · Cited by 52
“The p38 MAPK pathway is considered a key pathway mediating beiging for several other endogenous peptides (14, 17, 18).”
BackgroundMethodSelf-citationCurrent Evidence of the Role of the Myokine Irisin in Cancer
Tsiani, E., Tsakiridis, N., Kouvelioti, R., Jaglanian, A., & Klentrou, P. (2021) · Cancers · doi:10.3390/cancers13112628 · Cited by 51
“Two N‐glycosylation sites located at the Asn‐7 and Asn‐52 residues of irisin have been identified and early evidence indicates an important role of glycosylation on the biological activity and function [67].”
Background
Metadata
- Authors
- Zhang, Y., Li, R., Meng, Y., Li, S., Donelan, W., Zhao, Y., Qi, L., Zhang, M., Wang, X., Cui, T., Yang, L.-J., & Tang, D.
- Affiliations
- Shandong University (CN)
- Second Hospital of Shandong University (CN)
- University of Florida Health (US)
- Corresponding author
- Cui, Taixing
- Yang, Li-Jun
- Tang, Dongqi
- ORCID
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2014-01-16
- Volume
- 63
- Issue
- 2
- Pages
- 514-525
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC13117908
- OpenAlex
- W2121921343
- Cited by
- 733
- References
- 38
- Citations by year
- 2026: 28 · 2025: 49 · 2024: 53 · 2023: 45 · 2022: 80 · 2021: 83 · 2020: 70 · 2019: 48 · 2018: 53 · 2017: 68 · 2016: 55 · 2015: 63 · 2014: 35
- FWCI
- 36.11
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (K01DK080884)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Keywords
- irisin, white adipose tissue browning, p38 MAPK signaling, ERK signaling, UCP1, betatrophin, glucose homeostasis, obesity, type 2 diabetes, brown adipose tissue thermogenesis
- MeSH terms
- Mitochondrial Uncoupling Proteins, Animals, Adipose Tissue, Brown, Butadienes, Dietary Fats, Fibronectins, Imidazoles, Male, Mice, Inbred C57BL, Mutation, Nitriles, Pichia, Protein Binding, Pyridines, Recombinant Proteins, Rats, Sprague-Dawley, Adipocytes, MAP Kinase Signaling System, Membrane Transport Proteins, Caenorhabditis elegans Proteins, 3T3-L1 Cells, Extracellular Signal-Regulated MAP Kinases, p38 Mitogen-Activated Protein Kinases, Mice, Rats, Adipose Tissue, White
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.